{'fraction_non_alphanumeric': 0.03350083752093802, 'fraction_numerical': 0.031825795644891124, 'mean_word_length': 4.920792079207921, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Impact of COVID-19 on Plastic and Reconstructive Surgery Practice—Comparing Malaysia and Other Asian Countries: A Preliminary Study

COVID-19 emerged in late December 2019, from Wuhan, China, and as on date, March 2021, there have been 122.6 million cases worldwide (and still counting).1 All medical fraternities around the globe have been heavily affected by this pandemic, and plastic, reconstructive surgery (PRS) is no different as this specialty deals with both trauma and oncology. The aim of our study was to examine the effects of COVID-19 outbreak in the PRS specialty at an Asian scale.